Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,455 | 3,255 | 3,289 | 2,019 | 3,817 |
| Marketable Securities | 2,273 | 4,867 | 298 | 414 | 251 |
| Receivables | N/A | 73 | 112 | 321 | 197 |
| Other current assets | 102 | 0 | 2,507 | 0 | 0 |
| TOTAL | $6,830 | $8,195 | $6,206 | $2,754 | $4,265 |
| Non-Current Assets | |||||
| PPE Net | 2 | N/A | N/A | 10 | 11 |
| Intangibles | 380 | 380 | 380 | 253 | 1,037 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 10 |
| TOTAL | $382 | $380 | $380 | $263 | $1,058 |
| Total Assets | $7,212 | $8,575 | $6,586 | $3,017 | $5,323 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 232 | 253 | 300 | 330 | 436 |
| TOTAL | $232 | $253 | $300 | $330 | $436 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 2,667 | 0 | -2 |
| TOTAL | $N/A | $N/A | $2,667 | $N/A | $N/A |
| Total Liabilities | $232 | $253 | $2,967 | $330 | $436 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 5,142 | N/A | N/A |
| Common Shares | 13,182 | 13,182 | 13,182 | 6,624 | 6,606 |
| Retained earnings | -153,930 | -152,588 | -155,645 | -154,904 | -152,487 |
| Other shareholders' equity | 20 | 20 | 67 | 183 | 20 |
| TOTAL | $6,980 | $8,322 | $3,619 | $2,687 | $4,887 |
| Total Liabilities And Equity | $7,212 | $8,575 | $6,586 | $3,017 | $5,323 |